Engineering Semicarbazide‐Bearing Polypeptide Conjugates for Efficient Tumor Chemotherapy and Imaging of Tumor Metastasis
Advanced Materials · 2024
DOI: 10.1002/adma.202309315 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Materials, 2024. Verfasst von Wenhao Pan und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, The First Affiliated Hospital of University of Science and Technology of China (USTC), Division of Life Sciences and Medicine…. Hauptthemen laut MEDLINE: Neoplasms, Semicarbazones. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: National Key R&D Program of China, National Natural Science Foundation of China, Anhui Natural Science Fund.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Polypeptide materials offer scalability, biocompatibility, and biodegradability, rendering them an ideal platform for biomedical applications. However, the preparation of polypeptides with specific functional groups, such as semicarbazide moieties, remains challenging. This work reports, for the first time, the straightforward synthesis of well‐defined methoxy‐terminated poly(ethylene glycol)‐ b ‐polypeptide hybrid block copolymers (HBCPs) containing semicarbazide moieties. This synthesis involves implementing the direct polymerization of environment‐stable N ‐phenoxycarbonyl‐functionalized α‐amino acid (NPCA) precursors, thereby avoiding the handling of labile N ‐carboxyanhydride (NCA) monomers. The resulting HBCPs containing semicarbazide moieties enable facile functionalization with aldehyde/ketone derivatives, forming pH‐cleavable semicarbazone linkages for tailored drug release. Particularly, the intracellular pH‐triggered hydrolysis of semicarbazone moieties restores the initial semicarbazide residues, facilitating endo‐lysosomal escape and thus improving therapeutic outcomes. Furthermore, the integration of the hypoxic probe ( Ir(btpna)(bpy) 2 ) into the pH‐responsive nanomedicines allows sequential responses to acidic and hypoxic tumor microenvironments, enabling precise detection of metastatic tumors. The innovative approach for designing bespoke functional polypeptides holds promise for advanced drug delivery and precision therapeutics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, The First Affiliated Hospital of University of Science and Technology of China (USTC), Division of Life Sciences and Medicine, and Laboratory of Precision and Intelligent Chemistry, Department of…
- Anhui Provincial Key Laboratory of Precision Pharmaceutical Preparations and Clinical Pharmacy, Hefei, Anhui, 230001, China.
ORCID-Profile: Shiyong Liu
Förderung
- National Key R&D Program of China
- National Natural Science Foundation of China
- Anhui Natural Science Fund
- National Key Research and Development Program of China
Zitieren
APA
Pan, W., Zhang, L., Li, L., Cen, J., Song, R., Song, C., Zhang, G., Hu, J., & Liu, S. (2024). Engineering Semicarbazide‐Bearing Polypeptide Conjugates for Efficient Tumor Chemotherapy and Imaging of Tumor Metastasis. Advanced Materials. https://doi.org/10.1002/adma.202309315
Vancouver
Pan W, Zhang L, Li L, Cen J, Song R, Song C, et al. Engineering Semicarbazide‐Bearing Polypeptide Conjugates for Efficient Tumor Chemotherapy and Imaging of Tumor Metastasis. Advanced Materials. 2024. doi:10.1002/adma.202309315
BibTeX
@article{Pan2024,
author = {Pan, Wenhao and Zhang, Lei and Li, Lei and Cen, Jie and Song, Rundi and Song, Chengzhou and Zhang, Guoying and Hu, Jinming and Liu, Shiyong},
title = {Engineering Semicarbazide‐Bearing Polypeptide Conjugates for Efficient Tumor Chemotherapy and Imaging of Tumor Metastasis},
journal = {Advanced Materials},
year = {2024},
doi = {10.1002/adma.202309315}
}
EUVIMED